/Investor DB

SR One Capital Management — 2016 Investments

5 investments dated 2016 · listed companies and verified rows first · show all

Progynyprogyny.comin𝕏NASDAQ: PGNYSeries B · Jul 2016 · $15M

Progyny provides employer-sponsored women's health and family-building benefits, covering preconception, fertility, pregnancy and postpartum, and menopause/midlife care through concierge support, digital tools, and a managed network of specialists.

Digital HealthFemTechHealthtechHR Tech

Gina Bartasi(Founder)inPeter Anevski(Chief Executive Officer and Director)

Co-investorsAurumKleiner PerkinsM VenturesSavano Capital PartnersUnion Grove Venture Partners

CRISPRcrisprtx.comin𝕏Oct 2016

CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology.

BiotechDeep TechHealthtechZug, CH

Emmanuelle Charpentier(Founder)Samarth Kulkarni(Chief Executive Officer and Chairman of the Board)inJames R. Kasinger(General Counsel and Secretary)inStephen Kennedy(Head of Technical Operations)inMegan Wherry Menner(Head of Human Resources)inNaimish Patel(Chief Medical Officer)in

Board seatSimeon J. George· per SEC Form D

Co-investorsAvoro Capital AdvisorsCLI VenturesKhosla VenturesNew Enterprise Associates (NEA)Versant VenturesWellington Management+2 more

Arch Oncology Incarchoncology.comSeries A · Aug 2016 · $86M

Co-investorsAvego BioScience CapitalBioGenerator VenturesPerot JainRiverVest Venture PartnersRoche Venture Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Bird Rock Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.